首页> 外文期刊>Experimental & Molecular Pathology >Role of B:T cell ratio in suppression of clinical signs: a model for silent MS.
【24h】

Role of B:T cell ratio in suppression of clinical signs: a model for silent MS.

机译:B:T细胞比例在抑制临床症状中的作用:沉默MS的模型。

获取原文
获取原文并翻译 | 示例
           

摘要

B10.S mice have been considered resistant to experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. However, sensitization with a myelin oligodendrocyte glycoprotein (MOG) peptide, MOG(92-106), induced clinical signs in 30% of mice and central nervous system (CNS) pathology in 93% of mice. Symptomatic mice had more demyelination, inflammation, perivascular cuffing and axonal damage in the CNS compared to asymptomatic mice, but no strong correlations between CNS pathology and clinical score were found. Interestingly, the ratio of B cells to T cells in cellular infiltrates correlated with clinical score. This suggests that the balance between B and T cells contributes to expression of clinical signs.
机译:B10.S小鼠被认为对实验性自身免疫性脑脊髓炎(一种多发性硬化症的动物模型)具有抗性。但是,用髓磷脂少突胶质细胞糖蛋白(MOG)肽MOG(92-106)致敏可在30%的小鼠中引起临床体征,在93%的小鼠中引起中枢神经系统(CNS)病理。与无症状的小鼠相比,有症状的小鼠在中枢神经系统中有更多的脱髓鞘,炎症,血管周围的套囊和轴突损伤,但是在中枢神经系统病理学和临床评分之间未发现强相关性。有趣的是,细胞浸润中B细胞与T细胞的比例与临床评分相关。这表明B细胞和T细胞之间的平衡有助于临床体征的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号